Management of Treatment-Experienced HIV-Infected Patients
Summary
- Few data are available on the optimal management of virologic failure with a first-line ritonavir-boosted PI regimen
- A systematic review of multiple randomized, controlled trials of virologic failure with first-line ritonavir-boosted PI–based regimens showed that reinforced adherence and maintenance of the original regimen was as likely to result in virologic suppression as a modification in therapy[Zheng 2014]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content